Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market, The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking the overall biologics market value from $162 billion in 2013 to more than $262 billion by 2019, says research and consulting firm by Publisher. The company’s latest report states that patent expirations of branded biologics and the introduction of clearer regulatory frameworks for biosimilars after 2019 will see the latter capturing the market share from biologics.